Detalles de la búsqueda
1.
Letermovir prophylaxis for cytomegalovirus reactivation in allogeneic hematopoietic cell transplant recipients: Single center Canadian data.
Eur J Haematol
; 112(2): 301-309, 2024 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-37830403
2.
Multiplex proteomics in the identification of potential biomarkers of very severe sinusoidal obstruction syndrome/veno-occlusive disease (SOS/VOD) in allogeneic hematopoietic cell transplant patients treated with defibrotide.
Acta Haematol
; 2024 Feb 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-38330921
3.
Clonal hematopoiesis in the donor does not adversely affect long-term outcomes following allogeneic hematopoietic stem cell transplantation: result from a 13-year follow-up.
Haematologica
; 108(7): 1817-1826, 2023 Jul 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-36727396
4.
Impact of age on hospitalization and outcomes post allogeneic hematopoietic cell transplantation outcome, a single center experience.
Ann Hematol
; 102(4): 917-926, 2023 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-36820907
5.
Influence of conditioning regimen intensity on outcomes post-allogeneic hematopoietic cell transplantation for acute myeloid leukemia in complete morphological remission.
Eur J Haematol
; 111(4): 553-561, 2023 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-37461810
6.
Prognostic implication of pre-transplant FEV1 on long-term outcomes following allogeneic hematopoietic stem cell transplantation.
Eur J Haematol
; 111(5): 687-696, 2023 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-37491877
7.
Multiplex proteomics using proximity extension assay for the identification of protein biomarkers predictive of acute graft-vs.-host disease in allogeneic hematopoietic cell transplantation.
Clin Chem Lab Med
; 61(6): 1005-1014, 2023 05 25.
Artículo
en Inglés
| MEDLINE | ID: mdl-36655501
8.
Weight loss post-allogeneic stem cell transplant is associated with increased transplant-related mortality.
Support Care Cancer
; 31(10): 564, 2023 Sep 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-37676349
9.
Anti-thymocyte globulin and post-transplant cyclophosphamide predisposes to inferior outcome when using cryopreserved stem cell grafts.
Eur J Haematol
; 108(1): 61-72, 2022 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-34606661
10.
Anti-thymocyte Globulin and Post-Transplant Cyclophosphamide do not abrogate the inferior outcome risk conferred by human leukocyte antigen-A and -B mismatched donors.
Eur J Haematol
; 108(4): 288-297, 2022 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-34905239
11.
Allogeneic hematopoietic stem cell transplantation in patients with therapy-related hematologic malignancies developing after multiple myeloma.
Eur J Haematol
; 108(5): 430-436, 2022 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-35100661
12.
Moderate-severe grade of chronic graft versus host disease and younger age (less than 45 years old) are risk factors for avascular necrosis in adult patients undergoing allogeneic hematopoietic cell transplantation.
Ann Hematol
; 100(5): 1311-1319, 2021 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-33710366
13.
Pretransplant bone marrow cellularity and blood count recovery are not associated with relapse or survival risk following allogeneic stem cell transplant for AML in CR.
Eur J Haematol
; 107(3): 354-363, 2021 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-34076909
14.
Prolactin, a potential biomarker for chronic GVHD activity.
Eur J Haematol
; 106(2): 158-164, 2021 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-33047394
15.
Clinical prevalence and outcome of cardiovascular events in the first 100 days postallogeneic hematopoietic stem cell transplant.
Eur J Haematol
; 106(1): 32-39, 2021 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-32599663
16.
Refined hepatic grading system in chronic graft-versus-host disease improves prognostic risk stratification of long-term outcomes.
Eur J Haematol
; 106(4): 508-519, 2021 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-33421199
17.
Less Is More: Superior Graft-versus-Host Disease-Free/Relapse-Free Survival with Reduced-Intensity Conditioning and Dual T Cell Depletion in Acute Myelogenous Leukemia.
Biol Blood Marrow Transplant
; 26(8): 1511-1519, 2020 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-32422253
18.
Post-transplant cyclophosphamide combined with anti-thymocyte globulin for graft-vs-host disease prophylaxis improves survival and lowers non-relapse mortality in older patients undergoing allogeneic hematopoietic cell transplantation.
Ann Hematol
; 99(6): 1377-1387, 2020 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-32382774
19.
Influence of FLT3-ITD and NPM1 status on allogeneic hematopoietic cell transplant outcomes in patients with cytogenetically normal AML.
Eur J Haematol
; 102(4): 368-374, 2019 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-30706524
20.
Two BRM promoter polymorphisms predict poor survival in patients with hepatocellular carcinoma.
Mol Carcinog
; 57(1): 106-113, 2018 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-28892201